tetano
Editor, Senior Moderator
Med Rev (Berl)
. 2022 Mar 2;2(1):23-49.
doi: 10.1515/mr-2021-0023. eCollection 2022 Feb 1.
A review on COVID-19 transmission, epidemiological features, prevention and vaccination
Yuqin Zhang[SUP] 1 [/SUP], Gonghua Wu[SUP] 1 [/SUP], Shirui Chen[SUP] 1 [/SUP], Xu Ju[SUP] 1 [/SUP], Wumitijiang Yimaer[SUP] 1 [/SUP], Wangjian Zhang[SUP] 1 [/SUP], Shao Lin[SUP] 2 [/SUP], Yuantao Hao[SUP] 1 3 [/SUP], Jing Gu[SUP] 1 [/SUP], Jinghua Li[SUP] 1 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R[SUB]0[/SUB] of COVID-19 was 2.9 (95% CI: 2.7-3.1), and the estimates in Africa and Europe could be higher. The median R[SUB]t[/SUB] could decrease by 23-96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R[SUB]0[/SUB] in our meta-analysis, there should be at least 93.3% (95% CI: 89.9-96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness.
Keywords: COVID-19; SARS-CoV-2; coronavirus; pandemic; review.
. 2022 Mar 2;2(1):23-49.
doi: 10.1515/mr-2021-0023. eCollection 2022 Feb 1.
A review on COVID-19 transmission, epidemiological features, prevention and vaccination
Yuqin Zhang[SUP] 1 [/SUP], Gonghua Wu[SUP] 1 [/SUP], Shirui Chen[SUP] 1 [/SUP], Xu Ju[SUP] 1 [/SUP], Wumitijiang Yimaer[SUP] 1 [/SUP], Wangjian Zhang[SUP] 1 [/SUP], Shao Lin[SUP] 2 [/SUP], Yuantao Hao[SUP] 1 3 [/SUP], Jing Gu[SUP] 1 [/SUP], Jinghua Li[SUP] 1 [/SUP]
Affiliations
- PMID: 35658107
- PMCID: PMC9047653
- DOI: 10.1515/mr-2021-0023
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R[SUB]0[/SUB] of COVID-19 was 2.9 (95% CI: 2.7-3.1), and the estimates in Africa and Europe could be higher. The median R[SUB]t[/SUB] could decrease by 23-96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R[SUB]0[/SUB] in our meta-analysis, there should be at least 93.3% (95% CI: 89.9-96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness.
Keywords: COVID-19; SARS-CoV-2; coronavirus; pandemic; review.